查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541025

2024-2032 年按产品类型、材料、应用、最终用途（医院和诊所、门诊手术中心等）和地区分類的输尿管支架市场报告

Ureteral Stents Market Report by Product Type, Material, Application, End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球输尿管支架市场规模达3.749亿美元。泌尿系统疾病的日益普及、支架技术的新兴技术进步以及鼓励采用输尿管支架的政府优惠政策的实施是促进市场成长的一些主要因素。

输尿管支架是一种由医用级材料（例如硅胶或聚氨酯）製成的小型柔性管，用于泌尿科治疗各种泌尿道疾病。它被插入输尿管，即连接肾臟和膀胱的管子。它有多种用途，包括缓解阻塞、促进癒合和排水肾臟。它可以缓解肾结石、肿瘤或其他阻塞引起的输尿管阻塞。它使输尿管保持开放，使尿液能够从肾臟自由流入膀胱，从而防止併发症。此外，它是暂时的，需要定期监测和清除，并且在泌尿科护理中至关重要，可确保泌尿系统的健康和功能。

该市场主要由泌尿科技术进步所驱动。此外，更有效和微创的输尿管支架装置的开发正在影响市场的成长。此外，现代支架还改善了生物相容性，减少了结垢，并提高了患者的舒适度。因此，医疗保健专业人士更倾向于推荐和使用这些先进的支架，从而推动市场成长。此外，肾结石、泌尿道感染 (UTI) 和输尿管狭窄等泌尿系统疾病的发生率不断上升，并且正在加速产品的采用。这些情况通常需要插入输尿管支架作为治疗的一部分。除此之外，易患泌尿系统问题的老年人口不断增加也促进了市场的成长。同时，人们对泌尿系统疾病及其治疗方案的认识不断提高，导致更早的诊断和干预，使患者能够寻求医疗建议和治疗，并推动市场成长。

输尿管支架市场趋势/驱动因素：

泌尿系统疾病的盛行率不断上升

由于泌尿系统疾病发生率不断上升，市场受到了重大影响。此外，肾结石数量不断增加，是一种常见的泌尿系统疾病，其特征是在肾臟或尿道中形成固体肿块，阻塞输尿管，导致剧烈疼痛和潜在的肾臟损害，正在影响市场成长。此外，在此类病例中越来越多地使用输尿管支架来缓解阻塞并促进尿流，为患者提供缓解，同时避免更具侵入性的手术，从而促进了市场的成长。此外，不断增长的老年人口更容易患泌尿系统疾病，包括泌尿道感染、膀胱问题和良性前列腺增生 (BPH)。这些情况可能导致输尿管阻塞或併发症，需要使用支架进行诊断和治疗。此外，人们对泌尿系统疾病认识的提高和诊断技术的进步导致了早期检测和干预，从而加速了产品的采用。

支架领域的新兴技术进步

该市场是由显着的进步和创新推动的，这些进步和创新提高了输尿管支架的有效性并提高了患者的舒适度和结果。此外，传统支架通常由不可生物降解的材料製成，需要第二次移除程序。它导致了可生物降解支架的采用，随着时间的推移，支架会逐渐在体内溶解，消除了移除手术的需要，并减少了患者的不适。此外，采用药物洗脱技术，支架上涂有药物，可以缓慢释放到输尿管中，有助于预防发炎或感染等併发症，从而最大限度地减少副作用并增强支架的治疗效果，这是另一个主要的生长诱导因素。除此之外，三维（3D）列印技术的整合改变了支架设计，并允许根据患者独特的解剖结构创建客製化支架，确保更好的贴合性，减少刺激和不适，加速市场成长。

落实政府利多政策

鼓励采用输尿管支架的政府优惠政策的实施正在影响市场的成长。这些政策正在改善医疗保健的可近性、患者的治疗结果和成本效益。此外，政府措施包括宣传活动和补贴医疗保健计划，使患者能够使用支架，从而能够早期诊断和治疗影响市场成长的泌尿系统疾病。此外，多项优惠政策可以为医疗器材产业的研发提供财政诱因和补助，这是另一个主要的成长诱导因素。此外，公司正在投资开发更有效、更舒适和微创的先进支架，这正在促进市场成长。除此之外，政府措施鼓励新的市场参与者进入市场，产生多种支架选择，满足多种患者的需求和偏好，加速市场成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球输尿管支架市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 开口支架
    • 市场趋势
    • 市场预测
  • 闭端支架
    • 市场趋势
    • 市场预测
  • 双 J 型支架
    • 市场趋势
    • 市场预测
  • 多环支架
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依材料

  • 金属输尿管支架
    • 市场趋势
    • 市场预测
  • 聚合物输尿管支架
    • 市场趋势
    • 主要类型
      • 硅胶支架
      • 聚氨酯支架
      • 混合支架
    • 市场预测

第 8 章：市场区隔：按应用

  • 肾结石
    • 市场趋势
    • 市场预测
  • 肾臟移植
    • 市场趋势
    • 市场预测
  • 肿瘤
    • 市场趋势
    • 市场预测
  • 尿失禁
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：最终用途别

  • 医院和诊所
    • 市场趋势
    • 市场预测
  • 门诊手术中心 (ASC)
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Allium Medical Solutions Ltd.
    • B. Braun Melsungen AG
    • Biomerics
    • Boston Scientific Corporation
    • Becton Dickinson and Company
    • Coloplast Ltd.
    • Cook Group Incorporated
    • Medline Industries Inc.
    • Merit Medical Systems Inc.
    • Olympus Corporation
    • Teleflex Incorporated
Product Code: SR112024A3827

The global ureteral stents market size reached US$ 374.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 606.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. The growing prevalence of urological disorders, emerging technological advances in stent technology, and the implementation of favorable government policies encouraging the adoption of ureteral stents are some of the major factors contributing to the market growth.

A ureteral stent is a small, flexible tube produced of medical-grade materials, such as silicone or polyurethane, used in urology to manage various urinary tract conditions. It is inserted into the ureter, the tube connecting the kidney to the bladder. It serves various purposes, including relieving obstruction, facilitating healing, and draining the kidney. It alleviates blockages in the ureter caused by kidney stones, tumors, or other obstructions. It keeps the ureter open, allowing urine to rush freely from the kidney to the bladder, preventing complications. Additionally, it is temporary, requires periodic monitoring and removal, and is essential in urological care, ensuring the health and functionality of the urinary system.

The market is primarily driven by the technological advancements in urology. In addition, the development of more effective and minimally invasive ureteral stent devices is influencing the market growth. Also, modern stents offer improved biocompatibility, reduced encrustation, and enhanced patient comfort. As a result, healthcare professionals are more inclined to recommend and utilize these advanced stents, driving the market growth. Moreover, the rising incidences of urological disorders such as kidney stones, urinary tract infections (UTI), and ureteral strictures are accelerating product adoption. These conditions often require the insertion of ureteral stents as part of their treatment. Besides this, the growing geriatric population susceptible to urological issues contributes to market growth. Along with this, the rising awareness about urological disorders and their treatment options led to earlier diagnosis and intervention, allowing patients to seek medical advice and treatment and propelling the market growth.

Ureteral Stents Market Trends/Drivers:

The growing prevalence of urological disorders

The market has witnessed a significant impact due to the growing incidences of urological disorders. In addition, the increasing number of kidney stones, is a common urological condition characterized by the formation of solid masses in the kidney or urinary tract that obstruct the ureter, causing severe pain and potential kidney damage is influencing the market growth. Also, the increasing use of ureteral stents in such cases to relieve obstruction and promote urine flow, offering patients relief while avoiding more invasive procedures is augmenting the market growth. Moreover, the growing geriatric population is more susceptible to urological disorders, including urinary tract infections, bladder issues, and benign prostatic hyperplasia (BPH). These conditions can lead to ureteral obstructions or complications, requiring the use of stents for diagnostic and therapeutic purposes. Furthermore, the improved awareness of urological disorders and advancements in diagnostic techniques led to early detection and intervention, which is accelerating the product adoption.

The emerging technological advances in stents

The market is driven by significant advancements and innovations improving the effectiveness of ureteral stents and enhancing patient comfort and outcomes. In addition, traditional stents are typically produced from non-biodegradable materials, requiring a second procedure for removal. It led to the adoption of biodegradable stents, gradually dissolving within the body over time, eliminating the need for removal procedures and reducing patient discomfort. Moreover, the incorporation of drug-eluting technology, stents coated with medications that can be slowly released into the ureter, helping to prevent complications such as inflammation or infections which minimizes side effects and enhances the stent's therapeutic effect representing another major growth-inducing factor. Besides this, the integration of three-dimensional (3D) printing technology transforms stent design and allows for the creation of custom-made stents tailored to a patient's unique anatomy which ensures a better fit, reducing irritation and discomfort, accelerating the market growth.

The implementation of favorable government policies

The implementation of favorable government policies encouraging the adoption of ureteral stents is influencing the market growth. These policies are improving healthcare accessibility, patient outcomes, and cost-effectiveness. In addition, government initiatives include awareness campaigns and subsidized healthcare programs, making stents accessible to patients, allowing early diagnosis and treatment of urological conditions which is influencing the market growth. Moreover, several favorable policies can provide financial incentives and grants for research and development (R&D) in the medical device sector, representing another major growth-inducing factor. Also, companies are investing in developing advanced stents that are more effective, comfortable, and minimally invasive, which is augmenting the market growth. Besides this, government initiatives are encouraging new market players to enter the market leading to numerous stent options, catering to several patient needs and preferences, thus accelerating the market growth.

Ureteral Stents Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global ureteral stents market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, material, application and end use.

Breakup by Product Type:

Open End Stents

Closed End Stents

Double J-Stent

Multiloop Stents

Double J-stent represents the most popular product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes open-end stents, closed-end stents, double j-stent, and multiloop stents. According to the report, double j-stent accounted for the largest market share.

The double J-stent, also known as a double-pigtail stent, is a specialized product design characterized by its unique shape, which resembles the letter J with two curled ends. In addition, the double J-stent shape is optimized for stability and efficacy while the curled ends serve as anchors, securing the stent in place within the ureter, and influencing the market growth. It minimizes the risk of migration, where the stent may shift or dislodge from its intended position and ensures that the stent effectively facilitates urine drainage from the kidney to the bladder, preventing complications associated with ureteral obstructions.

Moreover, the double-pigtail shape reduces irritation and discomfort for patients and with improved patient comfort contributes to greater patient compliance and satisfaction, augmenting the market growth.

Besides this, the double J-stent is employed in clinical scenarios, from managing kidney stones and post-operative care to treating ureteral strictures which makes it a preferred choice for urologists and healthcare providers facing several patient needs.

Breakup by Material:

Metallic Ureteral Stents

Polymer Ureteral Stents

Silicone Stents

Polyurethane Stents

Hybrid Stents

Polymer ureteral stents presently account for the largest market share

A detailed breakup and analysis of the market based on the material has also been provided in the report. This includes metallic ureteral stents, polymer ureteral stents (silicone stents, polyurethane stents, and hybrid stents. According to the report, polymer ureteral stents accounted for the largest market share.

Polymer ureteral stents offer excellent biocompatibility and are well-tolerated by the body, minimizing the risk of allergic reactions or adverse tissue responses which makes them suitable for numerous patients, including those with sensitivities to other materials.

Moreover, polymer stents are highly flexible and can conform to the natural curvature of the ureter, allowing for a more comfortable placement procedure and reducing the risk of stent migration or discomfort for the patient which enables a better fit within the urinary tract, reducing the chances of irritation or obstruction.

Additionally, polymer ureteral stents are available in various sizes and configurations to cater to individual patient needs which ensures that urologists can select the most appropriate stent for each case, considering factors including the patient's anatomy and the specific urological condition.

Breakup by Application:

Kidney Stones

Kidney Transplantation

Tumors

Urinary Incontinence

Others

Kidney stones represent the largest market segment

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes kidney stones, kidney transplantation, tumors, urinary incontinence, and others. According to the report, kidney stones accounted for the largest market share.

Kidney stones, medically known as nephrolithiasis or renal calculi, are a widespread urological issue affecting millions of individuals. These small, hard mineral and salt deposits can form in the kidneys and, when they move into the ureter, cause excruciating pain and block urine flow. In addition, the rising product demand for alleviating pain and facilitating the passage of kidney stones by inserting a stent into the ureter to act as a conduit, keeping the ureter open, and allowing the stone to pass more comfortably is influencing the market growth. It reduces pain and minimizes the risk of complications such as infection or kidney damage associated with prolonged blockage.

Additionally, the prevalence of kidney stones due to dietary habits, dehydration, and lifestyle choices is escalating the product demand for kidney stone management, contributing to the market growth.

Moreover, advancements in stent technology improved the efficacy of stents in this application with the development of biodegradable stents, drug-eluting stents, and 3D-printed stents which are more patient-friendly and effective in facilitating the passage of kidney stones, representing another major growth-inducing factor.

Breakup by End Use:

Hospitals and Clinics

Ambulatory Surgical Centers (ASCs)

Others

Hospitals and clinics dominate the market

A detailed breakup and analysis of the market based on the end use has also been provided in the report. This includes hospitals and clinics, ambulatory surgical centers (ASCs), and others. According to the report, hospitals and clinics accounted for the largest market share.

Hospitals and clinics serve as primary points of care for patients with urological issues. In addition, hospitals are equipped with advanced medical facilities and expert urologists, are well-positioned to provide comprehensive care, including the insertion and monitoring of stents, contributing to the market growth.

Moreover, hospitals and clinics have the infrastructure and expertise to perform complex urological procedures, such as the insertion and removal of stents which often require specialized equipment and highly trained medical staff that hospitals and clinics can easily provide, representing another major growth-inducing factor.

Apart from this, the availability of numerous stent types and sizes is essential in addressing several needs of patients. Hospitals and clinics typically maintain a comprehensive inventory of ureteral stents, allowing them to select the most appropriate stent for each patient's specific condition and anatomy.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the majority of ureteral stents market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market.

The North America market is driven by the well-established healthcare infrastructure that promotes innovation and research. It offers world-renowned medical institutions, research centers, and urological experts which fosters a culture of continuous improvement, leading to the development and adoption of advanced technologies and treatments, including ureteral stents.

Moreover, the strong emphasis on patient care and comfort among healthcare providers aligning with the advancements in stent technology to enhance patient outcomes, represents another major growth-inducing factor. Patients in North America have access to the latest and most advanced medical treatments and devices, including advanced stents.

Along with this, North America's implementation of an enhanced regulatory framework ensures the safety and efficacy of medical devices, including ureteral stents, instilling confidence in healthcare professionals and patients regarding the reliability and performance of the products available in the market, propelling the market growth.

Competitive Landscape:

At present, key players in the market are actively implementing strategies to strengthen their positions and remain competitive in this dynamic healthcare segment. These strategies encompass various aspects, including innovation, partnerships, market expansion, and customer-centric approaches. They are investing in research and development (R&D) to create next-generation products including developing stents with advanced materials, drug-eluting capabilities, and improved designs to enhance patient comfort and reduce complications. Innovations such as smart stents with monitoring capabilities are also on the horizon. Moreover, several companies are entering strategic partnerships and collaborations with healthcare providers, research institutions, and academic centers which facilitate clinical trials, provide access to real-world patient data, and support the development of evidence-based solutions. Furthermore, key players are recognizing the importance of healthcare professionals and patients and focusing on customer-centric strategies involving comprehensive support services, including training for healthcare providers, educational resources for patients, and responsive customer service.

The market research report has provided a comprehensive analysis of the competitive landscape . Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Allium Medical Solutions Ltd.

B. Braun Melsungen AG

Biomerics

Boston Scientific Corporation

Becton, Dickinson and Company

Coloplast Ltd.

Cook Group Incorporated

Medline Industries Inc.

Merit Medical Systems Inc.

Olympus Corporation

Teleflex Incorporated

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In June 2022, Boston Scientific Corporation was recognized with a Bronze Edison Award in the Science and Medical category for its Tria Ureteral Stent, which is the first stent produced with a proprietary surface technology developed to offer protection against the accumulation of urine calcium and magnesium salt deposits.

In October 2020, Allium Medical Solutions Ltd., which specializes in minimally invasive technologies offer large markets with innovative solutions for clinical needs, announced that its urological stents received CE Mark for a new indication for treating urethral fistula after a successful trial.

In February 2023, Olympus Corporation, a global medtech company announced the acquisition of Taewoong Medical Co., Ltd, (Taewoong Medical), a Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents1 to strengthen its GI EndoTherapy product portfolio capabilities, enhancing patient outcome through comprehensive solutions.

Key Questions Answered in This Report

  • 1. What was the size of the global ureteral stents market in 2023?
  • 2. What is the expected growth rate of the global ureteral stents market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global ureteral stents market?
  • 4. What are the key factors driving the global ureteral stents market?
  • 5. What is the breakup of the global ureteral stents market based on the product type?
  • 6. What is the breakup of the global ureteral stents market based on the material?
  • 7. What is the breakup of the global ureteral stents market based on the application?
  • 8. What is the breakup of the global ureteral stents market based on the end use?
  • 9. What are the key regions in the global ureteral stents market?
  • 10. Who are the key players/companies in the global ureteral stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Ureteral Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Open End Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Closed End Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Double J-Stents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Multiloop Stents
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Metallic Ureteral Stents
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymer Ureteral Stents
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Silicone Stents
      • 7.2.2.2 Polyurethane Stents
      • 7.2.2.3 Hybrid Stents
    • 7.2.3 Market Forecast

8 Market Breakup by Application

  • 8.1 Kidney Stones
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Kidney Transplantation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Tumors
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Urinary Incontinence
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers (ASCs)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allium Medical Solutions Ltd.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Biomerics
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Boston Scientific Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Becton Dickinson and Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Coloplast Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Cook Group Incorporated
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Medline Industries Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Merit Medical Systems Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Olympus Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Teleflex Incorporated
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Ureteral Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Ureteral Stents Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Ureteral Stents Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Ureteral Stents Market: Breakup by Material (in %), 2023
  • Figure 6: Global: Ureteral Stents Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Ureteral Stents Market: Breakup by End Use (in %), 2023
  • Figure 8: Global: Ureteral Stents Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Ureteral Stents (Open End Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Ureteral Stents (Open End Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Ureteral Stents (Closed End Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Ureteral Stents (Closed End Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Ureteral Stents (Double J-Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Ureteral Stents (Double J-Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Ureteral Stents (Multiloop Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Ureteral Stents (Multiloop Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Ureteral Stents (Metallic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Ureteral Stents (Metallic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Ureteral Stents (Polymer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Ureteral Stents (Polymer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Ureteral Stents (Kidney Stones) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Ureteral Stents (Kidney Stones) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Ureteral Stents (Kidney Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Ureteral Stents (Kidney Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Ureteral Stents (Tumors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Ureteral Stents (Tumors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Ureteral Stents (Urinary Incontinence) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Ureteral Stents (Urinary Incontinence) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Ureteral Stents (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Ureteral Stents (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Ureteral Stents (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Ureteral Stents (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Ureteral Stents (Ambulatory Surgical Centers-ASCs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Ureteral Stents (Ambulatory Surgical Centers-ASCs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Ureteral Stents (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Ureteral Stents (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Ureteral Stents Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Ureteral Stents Industry: SWOT Analysis
  • Figure 87: Global: Ureteral Stents Industry: Value Chain Analysis
  • Figure 88: Global: Ureteral Stents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Ureteral Stents Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Ureteral Stents Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Ureteral Stents Market Forecast: Breakup by Material (in Million US$), 2024-2032
  • Table 4: Global: Ureteral Stents Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Ureteral Stents Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 6: Global: Ureteral Stents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Ureteral Stents Market: Competitive Structure
  • Table 8: Global: Ureteral Stents Market: Key Players